What is the current stock price of NeuroOne Medical Technologies Corporation (NMTC)?

As of the latest market data, NeuroOne Medical Technologies Corporation (NMTC) is trading at $3.73. The stock has seen a loss of -3.62% today.

Does NeuroOne Medical Technologies Corporation (NMTC) pay a dividend?

Based on current data, NeuroOne Medical Technologies Corporation does not have a confirmed active dividend policy.

NMTC

Q: What is the market cap of NeuroOne Medical Technologies Corporation?

The current market capitalization of NeuroOne Medical Technologies Corporation (NMTC) is approximately unavailable.

NeuroOne Medical Technologies Corporation·Healthcare

3.73

3.618%(−0.14)

Close Price

4.29

15.013%(+0.56)

Pre-Market

Last Updated: — ET

52W L: $3.2852W H: $6.96

NMTC NEWS

seekingalpha.com

May 12

NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript

defenseworld.net

Mar 25

Analyzing First Choice Healthcare Solutions (OTCMKTS:FCHS) & NeuroOne Medical Technologies (NASDAQ:NMTC)

First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Valuation and Earnings This

seekingalpha.com

Mar 12

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

defenseworld.net

Mar 5

Brokerages Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) PT at $1.98

Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a buy recommendation and one has assigned a strong

Company Profile

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2018-03-15

Beta

0.58

Websiten1mtc.com↗